Cargando…
A Review on Increasing the Targeting of PAMAM as Carriers in Glioma Therapy
Glioma is an invasive brain cancer, and it is difficult to achieve desired therapeutic effects due to the high postoperative recurrence rate and limited efficacy of drug therapy hindered by the biological barrier of brain tissue. Nanodrug delivery systems are of great interest, and many efforts have...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9599152/ https://www.ncbi.nlm.nih.gov/pubmed/36289715 http://dx.doi.org/10.3390/biomedicines10102455 |